Home/Filings/4/0001209191-20-023711
4//SEC Filing

McCamish Mark Anthony 4

Accession 0001209191-20-023711

CIK 0001667633other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 12:11 PM ET

Size

20.1 KB

Accession

0001209191-20-023711

Insider Transaction Report

Form 4
Period: 2020-04-07
McCamish Mark Anthony
DirectorPresident and CEO
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-07314,3950 total
    Exercise: $4.88Exp: 2027-06-07Common Stock (314,395 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-07334,2390 total
    Exercise: $5.27Exp: 2027-11-27Common Stock (334,239 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-07327,3750 total
    Exercise: $35.75Exp: 2029-12-12Common Stock (327,375 underlying)
  • Disposition to Issuer

    Common Stock

    2020-04-074,5950 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-07134,6290 total
    Exercise: $4.88Exp: 2027-08-14Common Stock (134,629 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-04-07184,5160 total
    Exercise: $8.76Exp: 2028-04-26Common Stock (184,516 underlying)
Footnotes (6)
  • [F1]Disposed of pursuant to an agreement and plan of merger by and between the Issuer, Gilead Sciences, Inc. ("Gilead") and Toro Merger Sub, Inc. ("Purchaser") (the "Merger") in exchange for $95.50 per share, net to the holder in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions described in the Offer to Purchase dated March 10, 2020 (together with any amendments or supplements thereto, the "Offer to Purchase") and in the accompanying Letter of Transmittal (together with any amendments or supplements thereto), which are annexed to and filed with the Schedule TO as Exhibits (a)(1)(A) and (a)(1)(B), respectively.
  • [F2]This option, which provided for vesting over a four year period as follows: (i) 96,773 shares subject to the option vested on May 1, 2018, and (ii) the balance of the shares subject to the option vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $28,489,688.91, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
  • [F3]This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning August 15, 2017, subject to the Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $12,199,743.41, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
  • [F4]This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning November 8, 2017, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $30,158,384.97, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
  • [F5]This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning March 1, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $16,005,379.13, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.
  • [F6]This option, which provided for vesting over a four-year period as follows: 1/48th of the shares subject to the option vest in a series of 48 successive equal monthly installments beginning December 13, 2019, subject to Reporting Person's continuous service as of each such date, was accelerated and canceled in the Merger in exchange for a cash payment of $19,560,656.25, representing the difference between the market value of the common stock underlying the option on the effective date of the Merger ($95.50 per share) and the exercise price applicable to each share of common stock underlying the option, which difference is multiplied by the total number of shares of common stock subject to the option.

Issuer

Forty Seven, Inc.

CIK 0001667633

Entity typeother

Related Parties

1
  • filerCIK 0001390798

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 12:11 PM ET
Size
20.1 KB